Annual Operating Expenses
$242.11 M
+$64.41 M+36.25%
December 31, 2023
Summary
- As of February 7, 2025, PHAR annual total operating expenses is $242.11 million, with the most recent change of +$64.41 million (+36.25%) on December 31, 2023.
- During the last 3 years, PHAR annual operating expenses has risen by +$129.73 million (+115.44%).
- PHAR annual operating expenses is now at all-time high.
Performance
PHAR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$63.92 M
-$5.31 M-7.67%
September 30, 2024
Summary
- As of February 7, 2025, PHAR quarterly total operating expenses is $63.92 million, with the most recent change of -$5.31 million (-7.67%) on September 30, 2024.
- Over the past year, PHAR quarterly operating expenses has increased by +$410.00 thousand (+0.65%).
- PHAR quarterly operating expenses is now -28.92% below its all-time high of $89.93 million, reached on December 31, 2023.
Performance
PHAR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PHAR Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.3% | +0.7% |
| 3 y3 years | +115.4% | +47.1% |
| 5 y5 years | +182.4% | +186.6% |
PHAR Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.5% | -28.9% | +125.9% |
| 5 y | 5-year | at high | +149.0% | -28.9% | +153.3% |
| alltime | all time | at high | >+9999.0% | -28.9% | +1640.4% |
Pharming Group NV Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $63.92 M(-7.7%) |
| Jun 2024 | - | $69.23 M(+9.0%) |
| Mar 2024 | - | $63.51 M(-29.4%) |
| Dec 2023 | $242.11 M(+36.3%) | $89.93 M(+59.3%) |
| Sep 2023 | - | $56.46 M(+28.7%) |
| Jun 2023 | - | $43.87 M(-15.8%) |
| Mar 2023 | - | $52.13 M(-22.1%) |
| Dec 2022 | $177.69 M(+12.0%) | $66.90 M(+51.7%) |
| Sep 2022 | - | $44.09 M(+55.8%) |
| Jun 2022 | - | $28.30 M(-27.3%) |
| Mar 2022 | - | $38.91 M(-10.4%) |
| Dec 2021 | $158.72 M(+41.2%) | $43.45 M(-10.7%) |
| Sep 2021 | - | $48.67 M(+42.5%) |
| Jun 2021 | - | $34.16 M(+5.3%) |
| Mar 2021 | - | $32.44 M(+2.9%) |
| Dec 2020 | $112.38 M(+15.6%) | $31.52 M(+10.0%) |
| Sep 2020 | - | $28.65 M(+13.5%) |
| Jun 2020 | - | $25.24 M(-6.4%) |
| Mar 2020 | - | $26.98 M(+0.8%) |
| Dec 2019 | $97.22 M(+13.4%) | $26.76 M(+20.0%) |
| Sep 2019 | - | $22.31 M(-21.5%) |
| Jun 2019 | - | $28.43 M(+44.2%) |
| Mar 2019 | - | $19.72 M(-24.1%) |
| Dec 2018 | $85.74 M(+29.3%) | $25.99 M(+25.0%) |
| Sep 2018 | - | $20.80 M(+10.0%) |
| Jun 2018 | - | $18.91 M(-5.6%) |
| Mar 2018 | - | $20.04 M(-16.2%) |
| Dec 2017 | $66.30 M(+177.3%) | $23.93 M(+46.5%) |
| Sep 2017 | - | $16.34 M(+5.7%) |
| Jun 2017 | - | $15.46 M(+46.3%) |
| Mar 2017 | - | $10.57 M(+45.8%) |
| Dec 2016 | $23.91 M | $7.25 M(+18.7%) |
| Sep 2016 | - | $6.11 M(+17.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $5.19 M(-3.1%) |
| Mar 2016 | - | $5.36 M(+5.7%) |
| Dec 2015 | $20.62 M(+14.0%) | $5.07 M(-8.2%) |
| Sep 2015 | - | $5.52 M(-6.3%) |
| Jun 2015 | - | $5.89 M(+42.3%) |
| Mar 2015 | - | $4.14 M(-4.5%) |
| Dec 2014 | $18.10 M(+3.6%) | $4.34 M(-19.1%) |
| Sep 2014 | - | $5.36 M(+36.8%) |
| Jun 2014 | - | $3.92 M(-12.6%) |
| Mar 2014 | - | $4.48 M(-10.5%) |
| Dec 2013 | $17.46 M(-41.5%) | $5.01 M(+16.0%) |
| Sep 2013 | - | $4.31 M(-3.4%) |
| Jun 2013 | - | $4.47 M(+21.6%) |
| Mar 2013 | - | $3.67 M(-57.3%) |
| Dec 2012 | $29.82 M(+28.3%) | $8.60 M(+17.2%) |
| Sep 2012 | - | $7.34 M(+3.4%) |
| Jun 2012 | - | $7.10 M(+4.5%) |
| Mar 2012 | - | $6.79 M(+64.4%) |
| Dec 2011 | $23.25 M(-19.2%) | $4.13 M(-32.1%) |
| Sep 2011 | - | $6.08 M(-2.5%) |
| Jun 2011 | - | $6.24 M(-8.2%) |
| Mar 2011 | - | $6.79 M(-26.3%) |
| Dec 2010 | $28.78 M(-28.3%) | $9.22 M(+44.0%) |
| Sep 2010 | - | $6.41 M(+15.2%) |
| Jun 2010 | - | $5.56 M(-16.8%) |
| Mar 2010 | - | $6.68 M(-22.4%) |
| Dec 2009 | $40.14 M(+11.1%) | $8.61 M(-14.4%) |
| Sep 2009 | - | $10.05 M(-15.4%) |
| Jun 2009 | - | $11.88 M(+36.5%) |
| Mar 2009 | - | $8.70 M |
| Dec 2008 | $36.12 M(-0.9%) | - |
| Dec 2007 | $36.46 M(-7838.4%) | - |
| Dec 2006 | -$471.20 K(-102.1%) | - |
| Dec 2005 | $22.32 M | - |
FAQ
- What is Pharming Group NV annual total operating expenses?
- What is the all time high annual operating expenses for Pharming Group NV?
- What is Pharming Group NV annual operating expenses year-on-year change?
- What is Pharming Group NV quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Pharming Group NV?
- What is Pharming Group NV quarterly operating expenses year-on-year change?
What is Pharming Group NV annual total operating expenses?
The current annual operating expenses of PHAR is $242.11 M
What is the all time high annual operating expenses for Pharming Group NV?
Pharming Group NV all-time high annual total operating expenses is $242.11 M
What is Pharming Group NV annual operating expenses year-on-year change?
Over the past year, PHAR annual total operating expenses has changed by +$64.41 M (+36.25%)
What is Pharming Group NV quarterly total operating expenses?
The current quarterly operating expenses of PHAR is $63.92 M
What is the all time high quarterly operating expenses for Pharming Group NV?
Pharming Group NV all-time high quarterly total operating expenses is $89.93 M
What is Pharming Group NV quarterly operating expenses year-on-year change?
Over the past year, PHAR quarterly total operating expenses has changed by +$410.00 K (+0.65%)